MORRISTOWN, N.J., March 7, 2025 /PRNewswire/ — Alvogen Pharma US, Inc. (“Alvogen” or the “Company”), a privately owned US-based pharmaceutical company, announced the successful completion of a comprehensive refinancing of its capital structure. Alvogen raised a $553 million first lien…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.